Profile

Current Profile

Health Advance, Inc. (OTCQB: HADV profiled @ $0.07) is a publicly held Wyoming corporation Health Advance Inc HADV HADV $HADVoperating as a distributor of cost-effective conventional pharmaceutical products and GRAS (Generally Referred to as Safe) regulated medical foods that contain botanical extract blends in efforts to treat cancer, epilepsy, PTSD, and other severe illnesses, working in cooperation with international dietary supplement and pharmaceutical developers.

Health Advance, Inc. is dedicated to providing value through quality, innovation, development, and growth of pharmaceutical products derived from an integration of organic and conventional product formulations. Our mission is to improve patient health, provide clinical practices with diversified therapeutic treatment options, and reduce the cost of harmful side effects of drugs on the healthcare system. Health Advance corporate website is HADVInc.com owns and operates HantianLabs.com, LeadingMedicalProducts.com, and BestTamanuOil.com.

Watch Health Advance Inc
(OTC: HADV) Brief Company Overview

Health Advance, Inc. is dedicated to providing value through quality, innovation, development, and growth of  pharmaceutical products derived from an integration of organic and conventional product formulations. Our mission is to improve patient health, provide clinical practices with diversified therapeutic treatment options, and reduce the cost of harmful side effects of drugs on the healthcare system.

Cebidiofen

Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).

Polyoxyfen

Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).

Current Research Pipeline

Our acquisition in North America of two patent pending product formulations, cebidiofen and polyoxyfen, in partnership with Micro Medtech, Ltd. have entered a phase two, product development plan with Nutrasource Diagnostics, Inc. for medical foods that meet Generally Recognized As Safe (GRAS) regulatory standards; a pipeline process that is planned to complete in June 2017.

News & Media

Corporate Headquarters
685 Citadel Drive East, Suite 290
Colorado Springs, CO 80909

Main Office: +1  (719) 466-6699
Corporate Website: http://HADVInc.com
eMail: info [at] hadvinc.com
Twitter: https://twitter.com/HealthAdvanceCo
FaceBook: click here

Health Advance Inc Facebook HADV #HADV $HADV
Health Advance Inc Twitter HADV #HADV $HADV

Previous Profiles

Cell MedX Corp. (OTCQB: CMXC profiled @ $0.32) is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.

The future of healthcare is a renewed priority and is dedicated to helping people stay healthy. Emerging practices and technologies are being used to detect and treat medical problems sooner and all with the ultimate goal of achieving better health outcomes. Traditionally, healthcare has evolved around treating illness with chemical (pharmaceuticals). However at Cell MedX, we have expanded the management of difficult chronic illnesses like diabetes to encompass electro-chemical methods of treatment and are achieving exceptional results. 

Many universities are still teaching that life is based on a chemical model. Given the explosive growth in electrical technologies and our ever increasing understanding of physics, it is more realistic in the 21st century to view biological processes on an electrochemical basis rather than on a chemical basis alone. What may seem like a subtle shift could have major implications for the healthcare industry. The growing aging population worldwide, the increasing number of people with chronic conditions, expanded regulatory requirements, insufficient healthcare resources, and rising costs are all burdening today’s health system, and creating the impetus for major changes.

Everyone knows they should have a healthy lifestyle, but knowing what to do and which tools to use can be overwhelming.

  • Patients can now manage diets, medications and health goals much easier.
  • In addition, social networking sites enable people to connect with others with the same medical issues to discuss options and available resources.
  • Combining this knowledge with the creation of effective medical devices now puts healthcare in a new medical context that is direct-to-consumer wellness.

At Cell MedX we are at the leading edge in the development of devices that treat chronic and acute conditions for both clinical and self-management care. We are pioneering safe, results oriented technologies combining electro-chemical applications and establishing new levels of treatment, known as cellular medicine.

Watch Cell MedX Corporate Video

Download Cell MedX
Corporate Presentation


Cell MedX Corp
74 N. Pecos, Suite D
Henderson, NV 89074
T: + 1-310-508-9398

Email: info@cellmedx.com

Website: http://www.cellmedx.com